Cargando…

Interplay of N-Cadherin and matrix metalloproteinase 9 enhances human nasopharyngeal carcinoma cell invasion

BACKGROUND: N-cadherin is a trans-membrane adhesion molecule associated with advanced carcinoma progression and poor prognosis. The effect of N-cadherin on matrix metalloproteinase 9 (MMP-9) regulation is implicated in human nasopharyngeal carcinoma (NPC) cell invasion. METHODS AND RESULTS: Exposure...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hsu, Chih-Chin, Huang, Shiang-Fu, Wang, Jong-Shyan, Chu, Wing-Keung, Nien, Ju-En, Chen, Wei-Shan, Chow, Shu-Er
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5064931/ https://www.ncbi.nlm.nih.gov/pubmed/27737648 http://dx.doi.org/10.1186/s12885-016-2846-4

Ejemplares similares

Caspase 12 degrades IκBα protein and enhances MMP-9 expression in human nasopharyngeal carcinoma cell invasion
por: Chu, Wing-Keung, et al.
Publicado: (2017)

Interplay between Matrix Metalloproteinase-9, Matrix Metalloproteinase-2, and Interleukins in Multiple Sclerosis Patients
por: Trentini, Alessandro, et al.
Publicado: (2016)

Assessment and clinicopathological correlation of matrix metalloproteinase 9 expression in nasopharyngeal carcinoma
por: Das, Ashok Kumar, et al.
Publicado: (2019)

Human Caspase 12 Enhances NF-κB Activity through Activation of IKK in Nasopharyngeal Carcinoma Cells
por: Chow, Shu-Er, et al.
Publicado: (2021)

Matrix Metalloproteinase-9: Its Interplay with Angiogenic Factors in Inflammatory Bowel Diseases
por: Matusiewicz, Malgorzata, et al.
Publicado: (2014)

Matrix metalloproteinase 13‐containing exosomes promote nasopharyngeal carcinoma metastasis
por: You, Yiwen, et al.
Publicado: (2015)

Molecular interactions of tannic acid and matrix metalloproteinases 2 and 9
por: Chiang, Ya-Tang, et al.
Publicado: (2023)

An interplay of microglia and matrix metalloproteinase MMP9 under hypoxic stress regulates the opticin expression in retina
por: Patnaik, Satish, et al.
Publicado: (2021)

Matrix metalloproteinase‐9 inhibition or deletion attenuates portal hypertension in rodents
por: Huang, Hui‐Chun, et al.
Publicado: (2021)

Matrix metalloproteinase activity stimulates N-cadherin shedding and the soluble N-cadherin ectodomain promotes classical microglial activation
por: Conant, Katherine, et al.
Publicado: (2017)

Matrix metalloproteinase-9 gene polymorphisms in nasal polyposis
por: Wang, Ling-Feng, et al.
Publicado: (2010)

Prediction of metastasis in oral squamous cell carcinoma through phenotypic evaluation and gene expression of E-cadherin, β-catenin, matrix metalloproteinase-2, and matrix metalloproteinase-9 biomarkers with clinical correlation
por: Sowmya, S. V., et al.
Publicado: (2020)

A nutrient mixture reduces the expression of matrix metalloproteinases in an animal model of spinal cord injury by modulating matrix metalloproteinase-2 and matrix metalloproteinase-9 promoter activities
por: ZHANG, HONGQI, et al.
Publicado: (2014)

Expression of vascular endothelial growth factor, matrix metalloproteinase-9 and E-cadherin in the process of lymph node metastasis in oesophageal cancer
por: Sato, F, et al.
Publicado: (1999)

Matrix metalloproteinase-7 and matrix metalloproteinase-9 are associated with unfavourable prognosis in superficial oesophageal cancer
por: Tanioka, Y, et al.
Publicado: (2003)

Interleukin-33, matrix metalloproteinase-9, and tissue ınhibitor of matrix metalloproteinase-1 in myocardial infarction
por: Guzel, Savas, et al.
Publicado: (2013)

Matrix Metalloproteinase-1 and Matrix Metalloproteinase-9 in the Aqueous Humor of Diabetic Macular Edema Patients
por: Kwon, Jin-woo, et al.
Publicado: (2016)

Important role of matrix metalloproteinase 9 in epileptogenesis
por: Wilczynski, Grzegorz M., et al.
Publicado: (2008)

Expression of Matrix Metalloproteinase-9 in Gastric Cancer
por: R, Prathipaa, et al.
Publicado: (2021)

Correlation between expression of matrix metalloproteinase-2 (MMP-2), and matrix metalloproteinase-9 (MMP-9) and angiogenesis in colorectal adenocarcinoma.
por: Kim, T. S., et al.
Publicado: (1999)

Hypoxia-Induced Matrix Metalloproteinase-13 Expression in Exosomes from Nasopharyngeal Carcinoma Enhances Metastases
por: Shan, Ying, et al.
Publicado: (2018)

Erratum: Interleukin-33, matrix metalloproteinase-9, and tissue inhibitor of matrix metalloproteinase-1 in myocardial infarction
por: Guzel, Savas, et al.
Publicado: (2013)

Elevated Expression of Matrix Metalloproteinase-9 not Matrix Metalloproteinase-2 Contributes to Progression of Extracranial Arteriovenous Malformation
por: Wei, Ting, et al.
Publicado: (2016)

Matrix Metalloproteinase-9 and Tissue Inhibitor of Matrix Metalloproteinase-1 in Sepsis after Major Abdominal Surgery
por: Bojic, Suzana, et al.
Publicado: (2018)

Combination of serum matrix metalloproteinase-3 activity and EBV antibodies improves the diagnostic performance of nasopharyngeal carcinoma
por: Li, Yiqiu, et al.
Publicado: (2020)

The Significance of Matrix Metalloproteinase 9 (MMP-9) and Metalloproteinase 2 (MMP-2) in Urinary Bladder Cancer
por: Kudelski, Jacek, et al.
Publicado: (2023)

Expression and Significance of Matrix Metalloproteinase-2 and Matrix Metalloproteinas-9 in Endometriosis
por: Barbe, Adrian Mykhailovych, et al.
Publicado: (2020)

Variants of the Matrix Metalloproteinase-2 but not the Matrix Metalloproteinase-9 genes significantly influence functional outcome after stroke
por: Manso, Helena, et al.
Publicado: (2010)

Expression and Concentration of Matrix Metalloproteinase 9 and Tissue Inhibitor of Matrix Metalloproteinases 1 in Laryngeal Squamous Cell Carcinoma
por: Matulka, Marlena, et al.
Publicado: (2019)

Plasma Matrix Metalloproteinase-9 and Tissue Inhibitor of Matrix Metalloproteinase-1 as Prognostic Biomarkers in Critically Ill Patients
por: Duda, Izabela, et al.
Publicado: (2020)

Correlation of matrix metalloproteinase 3 and matrix metalloproteinase 9 levels with non-motor symptoms in patients with Parkinson’s disease
por: Liu, Chuan Ze, et al.
Publicado: (2022)

Circulating Matrix Metalloproteinase-2 and -9 Enzyme Activities in the Children with Ventricular Septal Defect
por: Cheng, Kun-Shan, et al.
Publicado: (2013)

Haloperidol Abrogates Matrix Metalloproteinase-9 Expression by Inhibition of NF-κB Activation in Stimulated Human Monocytic Cells
por: Lee, Yueh-Lun, et al.
Publicado: (2018)

The cadherin–catenin complex in nasopharyngeal carcinoma
por: Galera-Ruiz, H., et al.
Publicado: (2011)

Elevated matrix metalloproteinase-9 in patients with systemic sclerosis
por: Kim, Wan-Uk, et al.
Publicado: (2005)

Matrix-metalloproteinase-9 is cleaved and activated by Cathepsin K
por: Christensen, Jon, et al.
Publicado: (2015)

The Role of Matrix Metalloproteinase-9 in Atherosclerotic Plaque Instability
por: Li, Tiewei, et al.
Publicado: (2020)

Matrix Metalloproteinase-9 as an Important Contributor to the Pathophysiology of Depression
por: Li, Hongmin, et al.
Publicado: (2022)

Injection of Matrix Metalloproteinase-9 Leads to Ventricular Remodeling
por: Zhu, Enzheng, et al.
Publicado: (2022)

Pathophysiological Role of Chymase-Activated Matrix Metalloproteinase-9
por: Takai, Shinji, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9hjihifdq2b4dnlo5c3idcdfbb